 |
Pulmocide
Last updated: October 06, 2024
Dan Burgess, CEO
UK | Funding: $205.5M (+)
Website: https://www.pulmocide.com
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.
Website: https://www.pulmocide.com
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.
